Matthew Gary, MD
Neurological Surgery · Atlanta, GANPI 1689833329
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,371 of the $35,894 with a category attached, or 79.0%. Joimax, Inc. accounts for 91.1% of it on its own, with 10 other manufacturers making up the rest.
Across 57 payments — averaging $629.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Joimax, Inc.$33K
- Medical Device Business Services, Inc.$1K
- Johnson & Johnson$573
- Stryker$463
- United Orthopedics LLC$407
- Nevro Corp.$243
- plus $416 from 5 others
Across 4 payments — averaging $4069.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tyber Medical, LLC$16K
What the payments were for
- Speaking & faculty fees$28,37179%
- Travel & lodging$5,44815%
- Food & beverage$1,9605%
- Entertainment$1150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Joimax, Inc. | 6 | $32,699 |
| Medical Device Business Services, Inc. | 16 | $1,093 |
| Johnson & Johnson | 17 | $573 |
| Stryker | 6 | $463 |
| United Orthopedics LLC | 2 | $407 |
| Nevro Corp. | 2 | $243 |
| Arthrex | 1 | $141 |
| Misonix Inc | 1 | $97 |
| Medtronic(2 entities) | 3 | $81 |
| Si-bone, Inc. | 1 | $68 |
| Globus Medical | 2 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIPER$853
- TRITANIUM$264
- Omnia$243
- Cerenovus Enterprise$150
- EVEREST SPINAL SYSTEM$124
How this compares
$35,894 in reported general payments places this provider in the 80th percentile of 201 neurological surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 99 | $1,151 |
| Oxycodone Hcl | 105 | $870 |
| Mupirocin | 100 | $672 |
| Methocarbamol | 53 | $514 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $513 |
| Pregabalin | 21 | $249 |
| Tizanidine Hcl | 13 | $196 |
| Tramadol Hcl | 44 | $182 |
| Methylprednisolone | 24 | $141 |
| Ondansetron OdtOndansetron | 14 | $90 |
| Prednisone | 28 | $50 |
| Cyclobenzaprine Hcl | 11 | $30 |
| Meloxicam | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Atlanta
- Regis HaidAtlanta$25.5M
- Thomas MorrisonAtlanta$2.8M
- Christopher TomarasAtlanta$1.5M
- Daniel RefaiAtlanta$1.2M
- Gerald RodtsAtlanta$1.2M
- James RobinsonAtlanta$993K
- Michele JohnsonAtlanta$540K
- David McCrackenAtlanta$425K
- Robert GrossAtlanta$315K
- Kaveh KhajaviAtlanta$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.